Cargando…
Phase II clinical development of new drugs
This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful exec...
Autores principales: | Ting, Naitee, Chen, Ding-Geng, Ho, Shuyen, Cappelleri, Joseph C |
---|---|
Lenguaje: | eng |
Publicado: |
Springer
2017
|
Materias: | |
Acceso en línea: | https://dx.doi.org/10.1007/978-981-10-4194-5 http://cds.cern.ch/record/2263533 |
Ejemplares similares
-
Design and analysis of subgroups with biopharmaceutical applications
por: Ting, Naitee, et al.
Publicado: (2020) -
Dose finding in drug development
por: Ting, Naitee
Publicado: (2006) -
22nd annual Applied Statistics Symposium of the International Chinese Statistical Association (ICSA), jointly with the International Society for Biopharmaceutical Statistics (ISBS)
por: Chen, Zhen, et al.
Publicado: (2015) -
Topological phase transitions and new developments
por: Brink, Lars, et al.
Publicado: (2019) -
New frontiers of biostatistics and bioinformatics
por: Zhao, Yichuan, et al.
Publicado: (2018)